• Print
  • Bookmark and Share
  • RSS Feeds Feeds

University of California (UCLA)

Stem Cell Transplant Program
1001 Westwood Blvd
Mezzanine Level
Los Angeles, CA 90095-7049
Direct phone: (310) 206-6100
http://www.cancer.mednet.ucla.edu

Program Description:

  The UCLA Adult and Pediatric Hematopoietic Stem Cell Transplant Program utilizes a multidisciplinary approach to patient care. Care is provided by a skilled team of clinicians and support staff.

Contact Information:

  If you have transplant-related questions, please contact M. "Tidi" Lambert, transplant center coordinator, at (310) 794-3013 or by e-mail at mlambert@mednet.ucla.edu.

Program Type:

  Adult (ages 18 to 75) and Pediatric (ages 1 to 17)

Attending Physicians:

(Medical Doctors)
 

Adult -

John Glaspy, Timmerman John, Ron Paquette, Lauren Pinter-Brown, Gary Schiller, Mary Territo, Sven de Vos

Pediatric -

Jackie Casillas, Christopher Denny, Stephen Feig, Cecilia Fu, Bridget Gomperts, Pamela Kempert, Joe Lasky, Theodore Moore, Kathleen Sakamoto

Transplants Performed:

  Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on:

  Adult and pediatric

Mismatches allowed:

For marrow, PBSC, or cord blood transplant with an unrelated donor. Match criteria may vary based on patient's age, disease type and stage.
 
Marrow/PBSC Cord Blood
Number: One Two
Location: DQ A or B antigen and DRB1 allele or antigen
helpExplain Transplant Center HLA Match Requirements

Estimated Search & Transplant Costs

Costs vary greatly from center to center, and depend on factors such as health insurance, disease type, and disease stage of the patient, as well as center-specific billing policies.
Activation of formal search:$750 - 1,950
DR testing of A/B tested donors (per donor):$335 - 970
Confirmatory typing blood sample (per sample):$345 - 2,130
IDM sample collection/testing (per donor):$215 - 980
High resolution - HLA typing:$215 - 1,335
Marrow or PBSC procurement:$14,475 - 39,850
Cord blood procurement (including shipping fees):$12,075 - 41,255

The costs listed above are only a small part of the total cost of a transplant. Contact your transplant center to learn more about costs of actual transplant and follow-up treatment.

helpExplain Transplant Costs at Different Centers

Financial Services:

Financial services at this center could include:

  • Health insurance information
  • Financial assistance
  • Patient-related resources

Resources for financial information

If you have questions about costs and financial services at this transplant center, you can contact the center's financial representative, Anita Jazwa at (310) 794-8156 or by e-mail at ajazwa@mednet.ucla.edu.

Many organizations exist to help patients with lodging, transportation and other transplant-related expenses. Visit the National Marrow Donor Program's Patient Organizations database for more information. Financial assistance resources are also listed on this Web site.

Transplant Experience

This center has been performing allogeneic transplants since 1973 and has been an NMDP transplant center since August 1993.

Center-Specific Analysis

This analysis is based on transplants performed from Jan. 1, 2002 through Dec 31, 2006, using unrelated NMDP donors. It only includes patients who were confirmed to be either alive or deceased within one year of transplant.
  1. This center reported survival status data for 96 patients.
  2. The overall disease condition of patients treated at this center was in the medium category (3 on a scale of 1 to 5).
  3. The actual one-year survival of these patients was 40.5%.
  4. The predicted one-year survival was 53.7% (with 95% statistical confidence that the predicted survival was between 44.2% and 63.1%).
  5. This center's actual results are below the predicted range for this center. National one-year estimated actual survival was 54.0% in the 8,847 patients transplanted in the United States.

For help with understanding these statistics, please see How to Understand NMDP Transplant Center Statistics.

Transplants Performed

(From Jan. 2002 - Dec. 2006)

Marrow

PBSC

Cord
Blood

Auto-
logous

Total

(by transplant type)

Total Non-
Myeloblative transplants*

Unrelated Donor - Adult 16 56 5 --- 77 20
Unrelated Donor - Pediatric 19 6 21 --- 46 0
Related Donor - Adult 16 121 0 --- 137 11
Related Donor - Pediatric 22 5 3 --- 30 0
Autologous (PBSC and Marrow) - Adult --- --- --- 394 394 ---
Autologous (PBSC and Marrow) - Pediatric --- --- --- 29 29 ---
Total (by cell source) 73 188 29 423 713 31

This center performed a total of 144 transplants, all types, in the most recent year (from June 2007 to May 2008)

*The total Non-Myeloblative transplants column shows a subset of the total number of transplants by type.

To locate centers that perform cord blood transplants, use the search tool on this site.

The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center.

helpExplain Transplant Experience

Survival by Patient's Age, Disease Type and Stage


This data is only based on unrelated transplants performed from Jan. 2002 to Dec. 2006. It also includes one year post-transplant follow-up, through Dec. 2007. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in the particular group.

Key:
CP = chronic phase (1st or 2nd) BP = blastic phase
AP = accelerated phase CR = complete remission (1st, 2nd, 3rd or more)
RLPS = relapse PIF = primary induction failure

Diagnoses

0-10
Yrs

11-17
Yrs

18-30
Yrs

31-40
Yrs

41-50
Yrs

51-60
Yrs

> 60
Yrs

Overall

Acute Bilineage Leukemia -- -- 1/1 -- -- -- -- 1/1
Acute Lymphoblastic Leukemia 1CR -- -- 1/1 0/1 -- 1/2 -- 2/4
Acute Lymphoblastic Leukemia 2CR 0/3 2/2 1/4 0/2 0/1 0/1 -- 3/13
Acute Lymphoblastic Leukemia 3+CR -- 2/4 1/1 -- -- -- -- 3/5
Acute Lymphoblastic Leukemia PIF -- -- 0/1 -- -- -- -- 0/1
Acute Lymphoblastic Leukemia RLPS -- -- 1/2 -- -- 0/1 -- 1/3
Acute Myelogenous Leukemia 1CR 1/1 -- -- -- 0/1 1/2 0/1 2/5
Acute Myelogenous Leukemia 2CR 1/2 3/3 1/2 -- 1/3 -- 0/1 6/11
Acute Myelogenous Leukemia 3+CR/RLPS -- -- -- 2/3 0/1 1/3 0/1 3/8
Acute Myelogenous Leukemia PIF 1/1 -- 0/3 -- -- 0/1 -- 1/5
Chronic Lymphocytic Leukemia -- -- -- -- 2/2 -- 1/1 3/3
Chronic Myelogenous Leukemia 1CP -- -- -- -- 1/1 -- -- 1/1
Chronic Myelogenous Leukemia 2CP -- 1/2 -- -- -- -- -- 1/2
Chronic Myelogenous Leukemia AP -- -- 0/1 -- 0/1 -- -- 0/2
Familial Erythrophagocytic Lymphohistiocytosis 1/1 -- -- -- -- -- -- 1/1
Fanconi Anemia -- 0/1 -- -- -- -- -- 0/1
Hemophagocytosis 0/1 -- -- -- -- -- -- 0/1
Hodgkin's Disease -- 1/1 3/3 1/2 -- -- -- 5/6
Juvenile Chronic Myelogenous Leukemia 0/1 -- -- -- -- -- -- 0/1
MDS-Other Myelodysplastic Disorder -- -- -- -- 0/1 -- -- 0/1
MDS-Refractory Anemia-Excess Blasts 1/1 -- -- 0/1 0/1 1/2 -- 2/5
Neutrophil Defect (Chediak-Higashi Syndrome) 1/1 -- -- -- -- -- -- 1/1
Non-Hodgkin's Lymphoma -- -- 0/1 0/3 0/1 0/4 0/2 0/11
Other Histiocytic Disorder 1/1 -- -- -- -- -- -- 1/1
Prolymphocytic Leukemia -- -- -- -- 0/1 -- -- 0/1
Severe Aplastic Anemia -- 2/2 -- -- -- -- -- 2/2
Total 7/13 11/15 9/20 3/12 4/14 4/16 1/6 39/96

helpExplain Survival by Patient Diagnosis and Age


Additional Information
Further information about this center, including the number and type of transplants performed in each of the last three years, and the support groups offered, may be found in the BMT InfoNet Transplant Center Directory: http://www.bmtinfonet.org/centers.

BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.